Skip to content

US Department of Defense – Peer Reviewed Medical Research Program

Home / Funding Opportunity / US Department of Defense – Peer Reviewed Medical Research Program

US Department of Defense – Peer Reviewed Medical Research Program

twitterlinkedin

Clinical Trial AwardHT942524PRMRPCTA 

  • undefined USD$ for up to 4 years (clinical trial only option) or
  • up to USD$500,000 for Planning Phase of up to 12 months plus undefined USD$ for up to 4 years planning phase with clinical trial option)
  • pre-proposals due 13 May 2024
  • Supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of a disease or condition in the Topic Area(s) of interest.
  • projects may range from small proof of-concept trials through large-scale, definitive trials.
  • Document: Funding Opportunity: HT942524PRMRPCTA-GG

 

Discovery AwardHT942524PRMRPDA 

  • up to USD$275,000 over 2 years
  • letters of intent due 6 May 2024
  • Supports innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies or applications.
  • clinical trials not allowed
  • Document: Funding Opportunity: HT942524PRMRPDA-GG

 

Investigator-Initiated Research AwardHT942524PRMRPIIRA 

  • up to USD$1M over 4 years
  • letters of intent due 6 May 2024
  • supports research that will make an important contribution toward research, patient care, and/or quality of life for a disease in the Topic Area(s) of interest
  • clinical trials not allowed
  • Document: Funding Opportunity: HT942524PRMRPIIRA-GG

 

Impact AwardHT942524PRMRPIPA

  • up to USD$2M over 4 years (single investigators) or
  • up to USD$2.6M over 4 years (partnering investigators)
  • letters of intent due 13 May 2024
  • Supports applied research, defined as use inspired and practice-oriented science that brings together outcomes from basic research, and insights from real-world environment to foster clinical applicability in the Topic Area(s) of interest.
  • clinical trials not allowed
  • Document: Funding Opportunity: HT942524PRMRPIPA-GG

 

Lifestyle and Behavioral Health Interventions Award – HT942524PRMRPLBIRA 

  • up to USD$3M over 4 years
  • letters of intent due 13 May 2024
  • supports using a combination of scientific disciplines including behavioral health, psychology, psychometrics, biostatistics and epidemiology, surveillance and public health that will enhance patient experience and improve outcomes
  • may include clinical research or clinical trails for interventions that do not require FDA regulation
  • patient advocate participation in the research team is encourage
  • animal studies not allowed
  • Document: Funding Opportunity: HT942524PRMRPLBIRA-GG

 

Technology/Therapeutic Development Award – HT942524PRMRPTTDA

  • up to USD$4M over 4 years
  • letters of intent due 13 May 2024
  • Supports translation of promising preclinical findings into products for clinical applications including prevention, detection, diagnosis, treatment, and/or quality of life.
  • Supports product-oriented projects (eg device, drug, clinical guidelines). The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device, or a knowledge-based product.
  • clinical trials not allowed
  • Document: Funding Opportunity: HT942524PRMRPTTDA-GG

 

Topic Areas of Interest

Autoimmune disorders and immunology –  celiac disease; computational biology for precision health; food allergies; Guillain-Barre syndrome; inflammatory bowel disease; proteomics; scleroderma

Cardiovascular Health  – computational biology for precision health; congenital heart disease; proteomics; vascular malformations

Infectious Diseases – computational biology for precision health; congenital cytomegalovirus; far-UVC germicidal light; hepatitis B; malaria; proteomics

Internal Medicine – accelerated aging processes associated with military service; computational biology for precision health; focal segmental glomerulosclerosis; interstitial cystitis; lymphedema; nephrotic syndrome; pancreatitis; polycystic kidney disease; proteomics

Neuroscience -computational biology for precision health; eating disorders; maternal mental health; myalgic encephalomyelitus/chronic fatigue syndrome; neuroactive steroids; peripheral neuropathy; proteomics; suicide prevention

Orthopaedic Medicine – accelerated aging processes associated with military service; computational biology for precision health; musculoskeletal disorders related to acute and chronic bone conditions and injuries; proteomics

Rare Diseases and Conditions – computational biology for precision health; dystonis; Ehlers-Danlos syndrome; epidermolysis bullosa; fibrous dyspasia/McCune-Albright syndrome; fragile X; fronttemporal degeneration; hereditary ataxia; hydrocephalus; mitochondrial disease; myotonic dystrophy; proteomics; Rett syndrome; sickle-cell disease; von Hippel-Lindau syndrome

Respiratory Health – computational biology for precision health; proteomics; pulmonary fibrosis; respiratory health

 

Apply here

Document

Peer Reviewed Medical Research Program – Summary Table: FY24 PRMRP PA Reference Table

You may be also interested in ...